Cardiovascular Care in Patients With HIV (eBook)

Marshall J. Glesby, MD, PhDProfessor of Medicine, Healthcare Policy and ResearchWeill Cornell Medical CollegeDepartment of Medicine525 East 68th St., Box 97New York, NY 10065, USAE-mail: mag2005@med.cornell.edu   Merle Myerson, MD, EdD, FACC, FNLABassett Medical CenterDivision of CardiologyDirector, Preventive Cardiology Program & Lipid ClinicAttending CardiologistBassett Research InstituteMedical Director, Center for Clinical ResearchOne Atwell RoadDivision of CardiologyCooperstown, NY 13326, USATel: 607-547-3048E-mail: merle.myerson@bassett.org  

PART I

Chapter 1:  The Changing Face of HIV

Marshall J. Glesby, MD, PhD and Merle Myerson, MD, EdD

 

PART II

Chapter 2: Risk Prediction

Merle Myerson, MD, EdD

Chapter 3: Diagnosis and Management of Dyslipidemia

Merle Myerson, MD, EdD

Chapter 4: Hypertension in HIV

Merle Myerson, MD, EdD

Chapter 5: Diabetes, Pre-Diabetes and Metabolic Syndrome Among People Living with HIV

Sowmya Chandra Reddy, MD, William B. Moore, MD, Papita Rozario, MD, Amy H. Warriner, MD

Chapter 6: Obesity

Anjali Sharma, MD, MS

Chapter 7: Tobacco Use in Patients with HIV

Jonathan Shuter, MD, Andrea Weinberger, PhD

Chapter 8: Lifestyle

Hany Abdallah, MD, Vani Gandhi, MD.

 

PART III

Chapter 9: Coronary Artery Disease

Patricia Chavez, MD and Di Pan, D.O.

Chapter 10: Epidemiology and Clinical Approach to Heart Failure in Patients with HIV

Sadeer G Al-Kindi, MD and Chris T Longenecker, MD

Chapter 11: Pericardial Disease

Marshall J. Glesby, MD, PhD

Chapter 12: Pulmonary Arterial Hypertension in HIV

Udhay Krishnan, MD and Evelyn M. Horn, MD

 

PART IV

Chapter 13: Ischemic Stroke and TIA

Felicia C. Chow, MD, MAS

Chapter 14: Venous Thromboembolic Disease and Hypercoagulability in Human Immunodeficiency Virus Infection

Michael T. Bender, MD, Sarah L. O’Beirne, MB BCh BAO, PhD

 

PART V

Chapter 15: Cardiovascular and HIV Drug Interactions

John J. Faragon, Pharm.D., Nimish Patel, PharmD, PhD